Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma

PURPOSE: To investigate the use of pretreatment carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) as prognostic factors to determine survival in pancreatic adenocarcinoma. MATERIALS AND METHODS: A retrospective review of the medical records of patients who were diagnosed with pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyong Joo, Yi, Seung Woo, Chung, Moon Jae, Park, Seung Woo, Song, Si Young, Chung, Jae Bock, Park, Jeong Youp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635646/
https://www.ncbi.nlm.nih.gov/pubmed/23549809
http://dx.doi.org/10.3349/ymj.2013.54.3.643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3635646/
https://www.ncbi.nlm.nih.gov/pubmed/23549809
http://dx.doi.org/10.3349/ymj.2013.54.3.643

Ejemplares similares